Drug company pushes for all children under 2 to be vaccinated against pneumoniaBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7426.1249-a (Published 27 November 2003) Cite this as: BMJ 2003;327:1249
- Leanne Tite
The pharmaceutical company Wyeth has launched a campaign to persuade the UK government to extend the use of its children's pneumococcal vaccine to all children under the age of 2. Currently, the Department of Health recommends it use only in children who are at risk because of chronic disease.
The move follows recent data published in the New England Journal of Medicine showing indications of an early success for the US paediatric pneumococcal immunisation programme (2003;348:1737-46). Figures compiled by the Centers for Disease Control and Prevention, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial